Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 21, 2005The Journal of Infectious DiseasesOpen Access

Development and Characterization of a Severe Acute Respiratory Syndrome–Associated Coronavirus–Neutralizing Human Monoclonal Antibody That Provides Effective Immunoprophylaxis in Mice

View Full Paper
Ask AI
Bookmark
Share

Authors

TGThomas C. GreenoughUMass Memorial Medical CenterGBGregory J. BabcockVisterra (United States)ARAnjeanette RobertsNational Institutes of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Greenough et al. (2005) studied this question.

synapsesocial.com/papers/6a7201d9439bab0cabc3bbbdhttps://doi.org/10.1086/427242
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1A Direct Comparison of the Activities of Two Humanized Respiratory Syncytial Virus Monoclonal Antibodies: MEDI‐493 and RSHZl91999 · 87 citations
  2. 2A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS121938 · 20,329 citations
  3. 3Identification of a Receptor-Binding Domain of the Spike Glycoprotein of Human Coronavirus HCoV-229E2003 · 199 citations
  4. 4A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome2003 · 4,548 citations
  5. 5Retargeting of Coronavirus by Substitution of the Spike Glycoprotein Ectodomain: Crossing the Host Cell Species Barrier2000 · 372 citations